IL28B-Genotype Testing Now and in the Era of Direct-Acting Antiviral Agents

Ítems similars

• The Role of IL28B Genotype Testing in the Era of Direct Acting Antiviral Agents
  per: Osinusi, Anu, et al.
  Publicat: (2012)
• Hepatitis C Viral Kinetics in the Era of Direct Acting Antiviral Agents and IL28B
  per: Dahari, Harel, et al.
  Publicat: (2011)
• Utility of IL-28B Polymorphisms in the Era of Direct-Acting Antiviral Therapy
  per: Gordon, Stuart C.
  Publicat: (2011)
• HCV-Associated Nephropathies in the Era of Direct Acting Antiviral Agents
  per: Angeletti, Andrea, et al.
  Publicat: (2019)
• Understanding triphasic HCV decline during treatment in the era of IL28B polymorphisms and direct acting antiviral agents via mathematical modeling
  per: Dahari, Harel, et al.
  Publicat: (2012)